<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">33042137</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>04</Month>
        <Day>28</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>04</Month>
        <Day>28</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Electronic">1664-3224</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>11</Volume>
            <PubDate>
              <Year>2020</Year>
            </PubDate>
          </JournalIssue>
          <Title>Frontiers in immunology</Title>
          <ISOAbbreviation>Front Immunol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Sarcoidosis Epidemiology: Race Matters.</ArticleTitle>
        <Pagination>
          <StartPage>537382</StartPage>
          <MedlinePgn>537382</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">537382</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2020.537382</ELocationID>
        <Abstract>
          <AbstractText>Rather than a single disease entity, sarcoidosis may be a constellation of "sarcoidoses" with a characteristic pattern of organ involvement and clinic course, depending upon the triggering exposure and underlying epidemiologic factors such as race. This review examines the racial disparities inherent to sarcoidosis disease course and mortality and discusses factors that may be responsible for these findings. In the United States, black patients with sarcoidosis experience more severe pulmonary disease, more multiorgan involvement, and an overall worse prognosis with higher rates of hospitalization and mortality. Beyond inherent genotype, ascertainment and access to medical care, physician implicit bias, and patient perceived discrimination likely play a role. Moving forward, epidemiologic concepts can be used to formulate strategies for control, treatment, and even prevention of disease in black Americans at risk for developing life-altering or life-threatening sarcoidosis phenotypes. Identification and rectification of modifiable risk factors such as socioeconomic status, lack of insurance, and financial barriers to care as well as the incorporation of implicit bias training for physician will likely lead to improvement in discordant outcomes.</AbstractText>
          <CopyrightInformation>Copyright © 2020 Hena.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Hena</LastName>
            <ForeName>Kerry Maryse</ForeName>
            <Initials>KM</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, New York University, New York, NY, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>09</Month>
          <Day>15</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Front Immunol</MedlineTA>
        <NlmUniqueID>101560960</NlmUniqueID>
        <ISSNLinking>1664-3224</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001741" MajorTopicYN="Y">African Americans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012507" MajorTopicYN="Y">Sarcoidosis</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">black race/ethnicity</Keyword>
        <Keyword MajorTopicYN="Y">health equity</Keyword>
        <Keyword MajorTopicYN="Y">implicit bias</Keyword>
        <Keyword MajorTopicYN="Y">sarcoidosis</Keyword>
        <Keyword MajorTopicYN="Y">sarcoidosis epidemiology</Keyword>
        <Keyword MajorTopicYN="Y">sarcoidosis mortality</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>8</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>10</Month>
          <Day>12</Day>
          <Hour>5</Hour>
          <Minute>29</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2020</Year>
          <Month>10</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>4</Month>
          <Day>29</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">33042137</ArticleId>
        <ArticleId IdType="pmc">PMC7522309</ArticleId>
        <ArticleId IdType="doi">10.3389/fimmu.2020.537382</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Valeyre D, Prasse A, Nunes H, Uzunhan Y, Brillet P-Y, Müller-Quernheim J. Sarcoidosis. Lancet. (2014) 383:1155–67. 10.1016/S0140-6736(13)60680-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(13)60680-7</ArticleId>
            <ArticleId IdType="pubmed">24090799</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Westney GE, Judson MA. Racial and ethnic disparities in sarcoidosis: from genetics to socioeconomics. Clin Chest Med. (2006) 27:453–62. 10.1016/j.ccm.2006.04.002</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ccm.2006.04.002</ArticleId>
            <ArticleId IdType="pubmed">16880055</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arkema EV, Grunewald J, Kullberg S, Eklund A, Askling J. Sarcoidosis incidence and prevalence: a nationwide register-based assessment in Sweden. Eur Respiratory J. (2016) 48:1690–9. 10.1183/13993003.00477-2016</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1183/13993003.00477-2016</ArticleId>
            <ArticleId IdType="pubmed">27471207</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baughman R, Field S, Costabel U, Crystal R, Culver D, Drent M, et al. . Sarcoidosis in America: analysis based on health care use. Ann Am Thorac Soc. (2016) 13:1244–52. 10.1513/AnnalsATS.201511-760OC</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1513/AnnalsATS.201511-760OC</ArticleId>
            <ArticleId IdType="pubmed">27509154</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Coquart N, Cadelis G, Tressières B, Cordel N. Epidemiology of sarcoidosis in Afro-Caribbean people: a 7-year retrospective study in Guadeloupe. Int J Dermatol. (2014) 54:188–92. 10.1111/ijd.12633</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/ijd.12633</ArticleId>
            <ArticleId IdType="pubmed">24962008</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cozier YC, Berman JS, Palmer JR, Boggs DA, Serlin DM, Rosenberg L. Sarcoidosis in black women in the United States: data from the Black Women's Health Study. Chest. (2011) 139:144–50. 10.1378/chest.10-0413</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1378/chest.10-0413</ArticleId>
            <ArticleId IdType="pmc">PMC3014690</ArticleId>
            <ArticleId IdType="pubmed">20595459</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Duchemann B, Annesi-Maesano I, Naurois CJD, Sanyal S, Brillet P-Y, Brauner M, et al. . Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris. Eur Respiratory J. (2017) 50:1602419. 10.1183/13993003.02419-2016</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1183/13993003.02419-2016</ArticleId>
            <ArticleId IdType="pubmed">28775045</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dumas O, Abramovitz L, Wiley AS, Cozier YC, Camargo CA. Epidemiology of sarcoidosis in a prospective cohort study of U.S. Women. Ann Am Thoracic Soc. (2016) 13:67–71. 10.1513/AnnalsATS.201508-568BC</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1513/AnnalsATS.201508-568BC</ArticleId>
            <ArticleId IdType="pmc">PMC4722845</ArticleId>
            <ArticleId IdType="pubmed">26501211</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hillerdal G, Nöu E, Osterman K, Schmekel B. Sarcoidosis: epidemiology and prognosis. A 15-year European study. Am Rev Respir Dis. (1984) 130:29–32. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6742607</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rybicki BA, Major M, Popovich J, Jr, Maliarik MJ, Iannuzzi MC. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol. (1997) 145:234–41. 10.1093/oxfordjournals.aje.a009096</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/oxfordjournals.aje.a009096</ArticleId>
            <ArticleId IdType="pubmed">9012596</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ungprasert P, Crowson CS, Matteson EL. Influence of gender on epidemiology and clinical manifestations of sarcoidosis: a population-based retrospective cohort study 1976–2013. Lung. (2017) 195:87–91. 10.1007/s00408-016-9952-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00408-016-9952-6</ArticleId>
            <ArticleId IdType="pmc">PMC5291820</ArticleId>
            <ArticleId IdType="pubmed">27709291</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Keller AZ. Hospital, age, racial, occupational, geographical, clinical and survivorship characteristics in the epidemiology of sarcoidosis. Am J Epidemiol. (1971) 94:222–30. 10.1093/oxfordjournals.aje.a121316</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/oxfordjournals.aje.a121316</ArticleId>
            <ArticleId IdType="pubmed">5093653</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Izumi T.
Symposium: population differences in clinical features and prognosis of sarcoidosis throughout the world. Sarcoidosis. (1992) 9:S105–18.</Citation>
        </Reference>
        <Reference>
          <Citation>Rybicki BA, Iannuzzi MC, Frederick MM, Thompson BW, Rossman MD, Bresnitz EA, et al. . Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS). Am J Respir Crit Care Med. (2001) 164:2085–91. 10.1164/ajrccm.164.11.2106001</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1164/ajrccm.164.11.2106001</ArticleId>
            <ArticleId IdType="pubmed">11739139</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Iannuzzi MC, Maliarik MJ, Poisson LM, Rybicki BA. Sarcoidosis susceptibility and resistance HLA-DQB1 alleles in African Americans. Am J Respir Crit Care Med. (2003) 167:1225–31. 10.1164/rccm.200209-1097OC</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1164/rccm.200209-1097OC</ArticleId>
            <ArticleId IdType="pubmed">12615619</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rybicki BA, Walewski JL, Maliarik MJ, Kian H, Iannuzzi MC, ACCESS Research Group . The BTNL2 gene and sarcoidosis susceptibility in African Americans and Whites. Am J Hum Genet. (2005) 77:491–9. 10.1086/444435</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/444435</ArticleId>
            <ArticleId IdType="pmc">PMC1226214</ArticleId>
            <ArticleId IdType="pubmed">16080124</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Iannuzzi MC, Iyengar SK, Gray-McGuire C, Elston RC, Baughman RP, Donohue JF, et al. . Genome-wide search for sarcoidosis susceptibility genes in African Americans. Genes Immun. (2005) 6:509–18. 10.1038/sj.gene.6364235</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.gene.6364235</ArticleId>
            <ArticleId IdType="pubmed">15951742</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gray-McGuire C, Sinha R, Iyengar S, Millard C, Rybicki BA, Elston RC, et al. . Genetic characterization and fine mapping of susceptibility loci for sarcoidosis in African Americans on chromosome 5. Hum Genet. (2006) 120:420–30. 10.1007/s00439-006-0201-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00439-006-0201-6</ArticleId>
            <ArticleId IdType="pubmed">16896925</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thompson CL, Rybicki BA, Iannuzzi MC, Elston RC, Iyengar SK, Gray-McGuire C, et al. . Reduction of sample heterogeneity through use of population substructure: an example from a population of African American families with sarcoidosis. Am J Hum Genet. (2006) 79:606–13. 10.1086/507847</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/507847</ArticleId>
            <ArticleId IdType="pmc">PMC1592564</ArticleId>
            <ArticleId IdType="pubmed">16960797</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager H, Jr, Bresnitz EA, et al. . Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med. (2001) 164:1885–9. 10.1164/ajrccm.164.10.2104046</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1164/ajrccm.164.10.2104046</ArticleId>
            <ArticleId IdType="pubmed">11734441</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rabin DL, Thompson B, Brown KM, Judson MA, Huang X, Lackland DT, et al. . Sarcoidosis: social predictors of severity at presentation. Eur Respir J. (2004) 24:601–8. 10.1183/09031936.04.00070503</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1183/09031936.04.00070503</ArticleId>
            <ArticleId IdType="pubmed">15459139</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blair IV, Steiner JF, Havranek EP. Unconscious (implicit) bias and health disparities: where do we go from here?
Perm J. (2011) 15:71–78. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3140753</ArticleId>
            <ArticleId IdType="pubmed">21841929</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>LaVeist TA, Nickerson KJ, Bowie JV. Attitudes about racism, medical mistrust, and satisfaction with care among African American and white cardiac patients. Med Care Res Rev. (2000) 57(Suppl.1):146–61. 10.1177/1077558700057001S07</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/1077558700057001S07</ArticleId>
            <ArticleId IdType="pubmed">11092161</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beydoun MA, Poggi-Burke A, Zonderman AB, Rostant OS, Evans MK, Crews DC. Perceived discrimination and longitudinal change in kidney function among urban adults. Psychosom Med. (2017) 79:824–34. 10.1097/PSY.0000000000000478</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/PSY.0000000000000478</ArticleId>
            <ArticleId IdType="pmc">PMC5595064</ArticleId>
            <ArticleId IdType="pubmed">28445210</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beatty Moody DL, Taylor AD, Leibel DK, Al-Najjar E, Katzel LI, Davatzikos C, et al. . Lifetime discrimination burden, racial discrimination, and subclinical cerebrovascular disease among African Americans. Health Psychol. (2019) 38:63–74. 10.1037/hea0000638</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1037/hea0000638</ArticleId>
            <ArticleId IdType="pmc">PMC6483094</ArticleId>
            <ArticleId IdType="pubmed">30474995</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Judson MA, Baughman RP, Thompson BW, Teirstein AS, Terrin ML, Rossman MD, et al. . Two year prognosis of sarcoidosis: the ACCESS experience. Sarcoidosis Vasc Diffuse Lung Dis. (2003) 20:204–11. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14620163</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Judson MA, Boan AD, Lackland DT. The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States. Sarcoidosis Vasc Diffuse Lung Dis. (2012) 29:119–27. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23461074</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Foreman MG, Mannino DM, Kamugisha L, Westney GE. Hospitalization for patients with sarcoidosis:1979–2000. Sarcoidosis Vasc Diffuse Lung Dis. (2006) 23:124–129. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17937108</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gerke AK, Yang M, Tang F, Cavanaugh JE, Polgreen PM. Increased hospitalizations among sarcoidosis patients from 1998 to 2008: a population-based cohort study. BMC Pulm Med. (2012) 12:19. 10.1186/1471-2466-12-19</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2466-12-19</ArticleId>
            <ArticleId IdType="pmc">PMC3391973</ArticleId>
            <ArticleId IdType="pubmed">22584044</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Swigris JJ, Olson AL, Huie TJ, Fernandez-Perez ER, Solomon J, Sprunger D, et al. . Sarcoidosis-related mortality in the United States from 1988 to 2007. Am J Respir Crit Care Med. (2011) 183:1524–30. 10.1164/rccm.201010-1679OC</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1164/rccm.201010-1679OC</ArticleId>
            <ArticleId IdType="pmc">PMC3137141</ArticleId>
            <ArticleId IdType="pubmed">21330454</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mirsaeidi M, Machado RF, Schraufnagel D, Sweiss NJ, Baughman RP. Racial difference in sarcoidosis mortality in the United States. Chest. (2015) 147:438–49. 10.1378/chest.14-1120</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1378/chest.14-1120</ArticleId>
            <ArticleId IdType="pmc">PMC4314818</ArticleId>
            <ArticleId IdType="pubmed">25188873</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gideon NM, Mannino DM. Sarcoidosis mortality in the United States 1979–1991: an analysis of multiple-cause mortality data. Am J Med. (1996) 100:423–7. 10.1016/S0002-9343(97)89518-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0002-9343(97)89518-6</ArticleId>
            <ArticleId IdType="pubmed">8610729</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cyrus E, Clarke R, Hadley D, Bursac Z, Trepka MJ, Devieux JG, et al. . The impact of COVID-19 on African American communities in the United States. medRxiv [Preprint]. (2020). 10.1101/2020.05.15.20096552</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1101/2020.05.15.20096552</ArticleId>
            <ArticleId IdType="pubmed">0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Williams DR, Neighbors HW, Jackson JS. Racial/ethnic discrimination and health: findings from community studies. Am J Public Health. (2008) 98(9Suppl.):S29–37. 10.2105/AJPH.98.Supplement_1.S29</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2105/AJPH.98.Supplement_1.S29</ArticleId>
            <ArticleId IdType="pmc">PMC2518588</ArticleId>
            <ArticleId IdType="pubmed">18687616</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hardeman RR, Medina EM, Boyd RW. Stolen breaths. N Engl J Med. (2020) 383:197–9. 10.1056/NEJMp2021072</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMp2021072</ArticleId>
            <ArticleId IdType="pubmed">32521156</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jones CP. Systems of power, axes of inequity: parallels, intersections, braiding the strands. Med Care. (2014) 52(10Suppl.3):S71–5. 10.1097/MLR.0000000000000216
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MLR.0000000000000216</ArticleId>
            <ArticleId IdType="pubmed">25215922</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">33042137</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>04</Month>
        <Day>28</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>04</Month>
        <Day>28</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Electronic">1664-3224</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>11</Volume>
            <PubDate>
              <Year>2020</Year>
            </PubDate>
          </JournalIssue>
          <Title>Frontiers in immunology</Title>
          <ISOAbbreviation>Front Immunol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Sarcoidosis Epidemiology: Race Matters.</ArticleTitle>
        <Pagination>
          <StartPage>537382</StartPage>
          <MedlinePgn>537382</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">537382</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2020.537382</ELocationID>
        <Abstract>
          <AbstractText>Rather than a single disease entity, sarcoidosis may be a constellation of "sarcoidoses" with a characteristic pattern of organ involvement and clinic course, depending upon the triggering exposure and underlying epidemiologic factors such as race. This review examines the racial disparities inherent to sarcoidosis disease course and mortality and discusses factors that may be responsible for these findings. In the United States, black patients with sarcoidosis experience more severe pulmonary disease, more multiorgan involvement, and an overall worse prognosis with higher rates of hospitalization and mortality. Beyond inherent genotype, ascertainment and access to medical care, physician implicit bias, and patient perceived discrimination likely play a role. Moving forward, epidemiologic concepts can be used to formulate strategies for control, treatment, and even prevention of disease in black Americans at risk for developing life-altering or life-threatening sarcoidosis phenotypes. Identification and rectification of modifiable risk factors such as socioeconomic status, lack of insurance, and financial barriers to care as well as the incorporation of implicit bias training for physician will likely lead to improvement in discordant outcomes.</AbstractText>
          <CopyrightInformation>Copyright © 2020 Hena.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Hena</LastName>
            <ForeName>Kerry Maryse</ForeName>
            <Initials>KM</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, New York University, New York, NY, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>09</Month>
          <Day>15</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Front Immunol</MedlineTA>
        <NlmUniqueID>101560960</NlmUniqueID>
        <ISSNLinking>1664-3224</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001741" MajorTopicYN="Y">African Americans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012507" MajorTopicYN="Y">Sarcoidosis</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">black race/ethnicity</Keyword>
        <Keyword MajorTopicYN="Y">health equity</Keyword>
        <Keyword MajorTopicYN="Y">implicit bias</Keyword>
        <Keyword MajorTopicYN="Y">sarcoidosis</Keyword>
        <Keyword MajorTopicYN="Y">sarcoidosis epidemiology</Keyword>
        <Keyword MajorTopicYN="Y">sarcoidosis mortality</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>8</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>10</Month>
          <Day>12</Day>
          <Hour>5</Hour>
          <Minute>29</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2020</Year>
          <Month>10</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>4</Month>
          <Day>29</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">33042137</ArticleId>
        <ArticleId IdType="pmc">PMC7522309</ArticleId>
        <ArticleId IdType="doi">10.3389/fimmu.2020.537382</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Valeyre D, Prasse A, Nunes H, Uzunhan Y, Brillet P-Y, Müller-Quernheim J. Sarcoidosis. Lancet. (2014) 383:1155–67. 10.1016/S0140-6736(13)60680-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(13)60680-7</ArticleId>
            <ArticleId IdType="pubmed">24090799</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Westney GE, Judson MA. Racial and ethnic disparities in sarcoidosis: from genetics to socioeconomics. Clin Chest Med. (2006) 27:453–62. 10.1016/j.ccm.2006.04.002</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ccm.2006.04.002</ArticleId>
            <ArticleId IdType="pubmed">16880055</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arkema EV, Grunewald J, Kullberg S, Eklund A, Askling J. Sarcoidosis incidence and prevalence: a nationwide register-based assessment in Sweden. Eur Respiratory J. (2016) 48:1690–9. 10.1183/13993003.00477-2016</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1183/13993003.00477-2016</ArticleId>
            <ArticleId IdType="pubmed">27471207</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baughman R, Field S, Costabel U, Crystal R, Culver D, Drent M, et al. . Sarcoidosis in America: analysis based on health care use. Ann Am Thorac Soc. (2016) 13:1244–52. 10.1513/AnnalsATS.201511-760OC</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1513/AnnalsATS.201511-760OC</ArticleId>
            <ArticleId IdType="pubmed">27509154</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Coquart N, Cadelis G, Tressières B, Cordel N. Epidemiology of sarcoidosis in Afro-Caribbean people: a 7-year retrospective study in Guadeloupe. Int J Dermatol. (2014) 54:188–92. 10.1111/ijd.12633</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/ijd.12633</ArticleId>
            <ArticleId IdType="pubmed">24962008</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cozier YC, Berman JS, Palmer JR, Boggs DA, Serlin DM, Rosenberg L. Sarcoidosis in black women in the United States: data from the Black Women's Health Study. Chest. (2011) 139:144–50. 10.1378/chest.10-0413</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1378/chest.10-0413</ArticleId>
            <ArticleId IdType="pmc">PMC3014690</ArticleId>
            <ArticleId IdType="pubmed">20595459</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Duchemann B, Annesi-Maesano I, Naurois CJD, Sanyal S, Brillet P-Y, Brauner M, et al. . Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris. Eur Respiratory J. (2017) 50:1602419. 10.1183/13993003.02419-2016</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1183/13993003.02419-2016</ArticleId>
            <ArticleId IdType="pubmed">28775045</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dumas O, Abramovitz L, Wiley AS, Cozier YC, Camargo CA. Epidemiology of sarcoidosis in a prospective cohort study of U.S. Women. Ann Am Thoracic Soc. (2016) 13:67–71. 10.1513/AnnalsATS.201508-568BC</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1513/AnnalsATS.201508-568BC</ArticleId>
            <ArticleId IdType="pmc">PMC4722845</ArticleId>
            <ArticleId IdType="pubmed">26501211</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hillerdal G, Nöu E, Osterman K, Schmekel B. Sarcoidosis: epidemiology and prognosis. A 15-year European study. Am Rev Respir Dis. (1984) 130:29–32. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6742607</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rybicki BA, Major M, Popovich J, Jr, Maliarik MJ, Iannuzzi MC. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol. (1997) 145:234–41. 10.1093/oxfordjournals.aje.a009096</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/oxfordjournals.aje.a009096</ArticleId>
            <ArticleId IdType="pubmed">9012596</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ungprasert P, Crowson CS, Matteson EL. Influence of gender on epidemiology and clinical manifestations of sarcoidosis: a population-based retrospective cohort study 1976–2013. Lung. (2017) 195:87–91. 10.1007/s00408-016-9952-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00408-016-9952-6</ArticleId>
            <ArticleId IdType="pmc">PMC5291820</ArticleId>
            <ArticleId IdType="pubmed">27709291</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Keller AZ. Hospital, age, racial, occupational, geographical, clinical and survivorship characteristics in the epidemiology of sarcoidosis. Am J Epidemiol. (1971) 94:222–30. 10.1093/oxfordjournals.aje.a121316</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/oxfordjournals.aje.a121316</ArticleId>
            <ArticleId IdType="pubmed">5093653</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Izumi T.
Symposium: population differences in clinical features and prognosis of sarcoidosis throughout the world. Sarcoidosis. (1992) 9:S105–18.</Citation>
        </Reference>
        <Reference>
          <Citation>Rybicki BA, Iannuzzi MC, Frederick MM, Thompson BW, Rossman MD, Bresnitz EA, et al. . Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS). Am J Respir Crit Care Med. (2001) 164:2085–91. 10.1164/ajrccm.164.11.2106001</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1164/ajrccm.164.11.2106001</ArticleId>
            <ArticleId IdType="pubmed">11739139</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Iannuzzi MC, Maliarik MJ, Poisson LM, Rybicki BA. Sarcoidosis susceptibility and resistance HLA-DQB1 alleles in African Americans. Am J Respir Crit Care Med. (2003) 167:1225–31. 10.1164/rccm.200209-1097OC</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1164/rccm.200209-1097OC</ArticleId>
            <ArticleId IdType="pubmed">12615619</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rybicki BA, Walewski JL, Maliarik MJ, Kian H, Iannuzzi MC, ACCESS Research Group . The BTNL2 gene and sarcoidosis susceptibility in African Americans and Whites. Am J Hum Genet. (2005) 77:491–9. 10.1086/444435</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/444435</ArticleId>
            <ArticleId IdType="pmc">PMC1226214</ArticleId>
            <ArticleId IdType="pubmed">16080124</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Iannuzzi MC, Iyengar SK, Gray-McGuire C, Elston RC, Baughman RP, Donohue JF, et al. . Genome-wide search for sarcoidosis susceptibility genes in African Americans. Genes Immun. (2005) 6:509–18. 10.1038/sj.gene.6364235</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.gene.6364235</ArticleId>
            <ArticleId IdType="pubmed">15951742</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gray-McGuire C, Sinha R, Iyengar S, Millard C, Rybicki BA, Elston RC, et al. . Genetic characterization and fine mapping of susceptibility loci for sarcoidosis in African Americans on chromosome 5. Hum Genet. (2006) 120:420–30. 10.1007/s00439-006-0201-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00439-006-0201-6</ArticleId>
            <ArticleId IdType="pubmed">16896925</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thompson CL, Rybicki BA, Iannuzzi MC, Elston RC, Iyengar SK, Gray-McGuire C, et al. . Reduction of sample heterogeneity through use of population substructure: an example from a population of African American families with sarcoidosis. Am J Hum Genet. (2006) 79:606–13. 10.1086/507847</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/507847</ArticleId>
            <ArticleId IdType="pmc">PMC1592564</ArticleId>
            <ArticleId IdType="pubmed">16960797</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager H, Jr, Bresnitz EA, et al. . Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med. (2001) 164:1885–9. 10.1164/ajrccm.164.10.2104046</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1164/ajrccm.164.10.2104046</ArticleId>
            <ArticleId IdType="pubmed">11734441</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rabin DL, Thompson B, Brown KM, Judson MA, Huang X, Lackland DT, et al. . Sarcoidosis: social predictors of severity at presentation. Eur Respir J. (2004) 24:601–8. 10.1183/09031936.04.00070503</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1183/09031936.04.00070503</ArticleId>
            <ArticleId IdType="pubmed">15459139</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blair IV, Steiner JF, Havranek EP. Unconscious (implicit) bias and health disparities: where do we go from here?
Perm J. (2011) 15:71–78. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3140753</ArticleId>
            <ArticleId IdType="pubmed">21841929</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>LaVeist TA, Nickerson KJ, Bowie JV. Attitudes about racism, medical mistrust, and satisfaction with care among African American and white cardiac patients. Med Care Res Rev. (2000) 57(Suppl.1):146–61. 10.1177/1077558700057001S07</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/1077558700057001S07</ArticleId>
            <ArticleId IdType="pubmed">11092161</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beydoun MA, Poggi-Burke A, Zonderman AB, Rostant OS, Evans MK, Crews DC. Perceived discrimination and longitudinal change in kidney function among urban adults. Psychosom Med. (2017) 79:824–34. 10.1097/PSY.0000000000000478</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/PSY.0000000000000478</ArticleId>
            <ArticleId IdType="pmc">PMC5595064</ArticleId>
            <ArticleId IdType="pubmed">28445210</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beatty Moody DL, Taylor AD, Leibel DK, Al-Najjar E, Katzel LI, Davatzikos C, et al. . Lifetime discrimination burden, racial discrimination, and subclinical cerebrovascular disease among African Americans. Health Psychol. (2019) 38:63–74. 10.1037/hea0000638</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1037/hea0000638</ArticleId>
            <ArticleId IdType="pmc">PMC6483094</ArticleId>
            <ArticleId IdType="pubmed">30474995</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Judson MA, Baughman RP, Thompson BW, Teirstein AS, Terrin ML, Rossman MD, et al. . Two year prognosis of sarcoidosis: the ACCESS experience. Sarcoidosis Vasc Diffuse Lung Dis. (2003) 20:204–11. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14620163</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Judson MA, Boan AD, Lackland DT. The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States. Sarcoidosis Vasc Diffuse Lung Dis. (2012) 29:119–27. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23461074</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Foreman MG, Mannino DM, Kamugisha L, Westney GE. Hospitalization for patients with sarcoidosis:1979–2000. Sarcoidosis Vasc Diffuse Lung Dis. (2006) 23:124–129. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17937108</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gerke AK, Yang M, Tang F, Cavanaugh JE, Polgreen PM. Increased hospitalizations among sarcoidosis patients from 1998 to 2008: a population-based cohort study. BMC Pulm Med. (2012) 12:19. 10.1186/1471-2466-12-19</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2466-12-19</ArticleId>
            <ArticleId IdType="pmc">PMC3391973</ArticleId>
            <ArticleId IdType="pubmed">22584044</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Swigris JJ, Olson AL, Huie TJ, Fernandez-Perez ER, Solomon J, Sprunger D, et al. . Sarcoidosis-related mortality in the United States from 1988 to 2007. Am J Respir Crit Care Med. (2011) 183:1524–30. 10.1164/rccm.201010-1679OC</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1164/rccm.201010-1679OC</ArticleId>
            <ArticleId IdType="pmc">PMC3137141</ArticleId>
            <ArticleId IdType="pubmed">21330454</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mirsaeidi M, Machado RF, Schraufnagel D, Sweiss NJ, Baughman RP. Racial difference in sarcoidosis mortality in the United States. Chest. (2015) 147:438–49. 10.1378/chest.14-1120</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1378/chest.14-1120</ArticleId>
            <ArticleId IdType="pmc">PMC4314818</ArticleId>
            <ArticleId IdType="pubmed">25188873</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gideon NM, Mannino DM. Sarcoidosis mortality in the United States 1979–1991: an analysis of multiple-cause mortality data. Am J Med. (1996) 100:423–7. 10.1016/S0002-9343(97)89518-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0002-9343(97)89518-6</ArticleId>
            <ArticleId IdType="pubmed">8610729</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cyrus E, Clarke R, Hadley D, Bursac Z, Trepka MJ, Devieux JG, et al. . The impact of COVID-19 on African American communities in the United States. medRxiv [Preprint]. (2020). 10.1101/2020.05.15.20096552</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1101/2020.05.15.20096552</ArticleId>
            <ArticleId IdType="pubmed">0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Williams DR, Neighbors HW, Jackson JS. Racial/ethnic discrimination and health: findings from community studies. Am J Public Health. (2008) 98(9Suppl.):S29–37. 10.2105/AJPH.98.Supplement_1.S29</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2105/AJPH.98.Supplement_1.S29</ArticleId>
            <ArticleId IdType="pmc">PMC2518588</ArticleId>
            <ArticleId IdType="pubmed">18687616</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hardeman RR, Medina EM, Boyd RW. Stolen breaths. N Engl J Med. (2020) 383:197–9. 10.1056/NEJMp2021072</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMp2021072</ArticleId>
            <ArticleId IdType="pubmed">32521156</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jones CP. Systems of power, axes of inequity: parallels, intersections, braiding the strands. Med Care. (2014) 52(10Suppl.3):S71–5. 10.1097/MLR.0000000000000216
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MLR.0000000000000216</ArticleId>
            <ArticleId IdType="pubmed">25215922</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
